Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Boston Scientific (NY:BSX)

64.44 +0.62 (+0.96%)

Streaming Delayed Price Updated: 3:15 PM EDT, Apr 15, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	6,826,863
Open	64.04
Bid (Size)	64.43 (400)
Ask (Size)	64.44 (800)
Prev. Close	63.82
Today's Range	63.70 - 65.15
52wk Range	60.59 - 109.50
Shares Outstanding	1,423,852,648
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Boston Scientific’s $14.9 Billion Bet: The Strategic "Homecoming" to Neurovascular Dominance

Today 11:54 EDT

As of April 15, 2026, the medical technology landscape is bracing for its most significant transformation in years. Boston Scientific (NYSE:BSX) is moving steadily toward the finalization of its $14.9...

Via MarketMinute

Consolidation Fever: Boston Scientific’s $14.9 Billion Bet on Penumbra Signals New Era in MedTech M&A

Today 10:30 EDT

In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN) for approximately...

Via MarketMinute

Performance

YTD	-32.0%	-32.0%
1 Month	-7.7%	-7.7%
3 Month	-31.6%	-31.6%
6 Month	-33.0%	-33.0%
1 Year	-31.6%	-31.6%

More News

Boston Scientific Corp (NYSE:BSX) Offers Affordable Growth for Value-Conscious Investors ↗

April 07, 2026

Via Chartmill

Wall Street’s Renaissance: Bank of America Shatters Q1 2026 Estimates as M&A and Trading Volatility Surge

Today 10:02 EDT

Via MarketMinute

MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat

April 14, 2026

Via MarketMinute

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX

April 14, 2026

From Pomerantz LLP

Via GlobeNewswire

Avanos Medical to be Acquired by American Industrial Partners for $1.27 Billion; Stock Surges 69%

April 14, 2026

Via MarketMinute

Johnson & Johnson Shatters Expectations in Q1 2026, Raising Full-Year Outlook as Healthcare Giant Pushes Toward $100 Billion Milestone

April 14, 2026

Via MarketMinute

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)

April 14, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

The Great Consolidation: Q1 2026 M&A Activity Shatters Records Amid $3 Trillion Private Equity Surge

April 09, 2026

Via MarketMinute

The Teleflex Pivot: Inside the $1 Billion Share Buyback and Strategic Breakup

April 09, 2026

Via Finterra

BOSTON SCIENTIFIC CORPORATION (BSX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline

April 09, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX

April 07, 2026

From Pomerantz LLP

Via GlobeNewswire

Hologic, Inc. (NASDAQ: HOLX): A New Chapter as a Women’s Health Powerhouse

April 07, 2026

Via Finterra

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)

April 07, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX

April 06, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Robotic Revolution in the Electrophysiology Lab: FDA Clears Stereotaxis Synchrony System

April 06, 2026

Via MarketMinute

Stereotaxis Secures FDA Clearance for Synchrony™ System, Completing Its Vision for the Robotic "Digital Cockpit"

April 06, 2026

Via MarketMinute

3 of Wall Street’s Favorite Stocks for Long-Term Investors

April 06, 2026

Via StockStory

The Martha Transformation: A Deep Dive into Medtronic’s 2026 Pivot

April 03, 2026

Via Finterra

The Great Unlocking: 2026 M&A Surge Ignites as Private Equity Confidence Hits Record 86%

April 02, 2026

Via MarketMinute

Med-Tech Resilience: AngioDynamics Pivot Pays Off with Double-Digit Growth and Profitability

April 02, 2026

Via MarketMinute

BOSTON SCIENTIFIC CORPORATION (BSX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline

April 02, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026

April 02, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

The Great Rebound: US Megadeals Surge 319% as Corporate Consolidation Returns with a Vengeance

April 01, 2026

Via MarketMinute

Frequently Asked Questions

Is Boston Scientific publicly traded?

Yes, Boston Scientific is publicly traded.

What exchange does Boston Scientific trade on?

Boston Scientific trades on the New York Stock Exchange

What is the ticker symbol for Boston Scientific?

The ticker symbol for Boston Scientific is BSX on the New York Stock Exchange

What is the current price of Boston Scientific?

The current price of Boston Scientific is 64.44

When was Boston Scientific last traded?

The last trade of Boston Scientific was at 04/15/26 03:15 PM ET

What is the market capitalization of Boston Scientific?

The market capitalization of Boston Scientific is 91.75B

How many shares of Boston Scientific are outstanding?

Boston Scientific has 92B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.